Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder

about

Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.Lisdexamfetamine: A Review in Binge Eating Disorder.

P2860

Q47289729-0D458AC7-CD90-4973-8D29-C93A40548B93 Q47652489-770B7926-1A0B-4A0D-A7A8-B7A212ED230B Q47663515-21137509-4C5C-4A2D-860F-1F48EBC0ACEE

P2860

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder

Item

http://www.wikidata.org/entity/Q41539924

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Time course of the effects of ...... lts with binge-eating disorder

@en

type

Item

label

Time course of the effects of ...... lts with binge-eating disorder

@en

prefLabel

Time course of the effects of ...... lts with binge-eating disorder

@en

P1476

Time course of the effects of ...... lts with binge-eating disorder

@en

P2093

Barry K Herman

http://www.w3.org/2001/XMLSchema#string

Denise Wilfley

http://www.w3.org/2001/XMLSchema#string

James I Hudson

http://www.w3.org/2001/XMLSchema#string

Jana Radewonuk

http://www.w3.org/2001/XMLSchema#string

Joan Busner

http://www.w3.org/2001/XMLSchema#string

Maria Gasior

http://www.w3.org/2001/XMLSchema#string

P2860

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.

Early response to antidepressant treatment in bulimia nervosa.

Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.

Validation of the yale-brown obsessive compulsive scale modified for binge eating.

A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.

Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.

P304

884-892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EAT.22722

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan L McElroy

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28481434

http://www.w3.org/2001/XMLSchema#string

P921

placebo

eating disorder

phase III clinical trial

P932

5573905

http://www.w3.org/2001/XMLSchema#string

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder

about

P2860

P2860

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932